FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

421155001: Gastro-resistant and prolonged-release oral tablet (dose form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3635961015 Gastro-resistant and prolonged-release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3635962010 Gastro-resistant and prolonged-release oral tablet (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Gastro-resistant and prolonged-release oral tablet Is a Extended-release tablet false Inferred relationship Some
Gastro-resistant and prolonged-release oral tablet Is a Gastro-resistant oral tablet (dose form) true Inferred relationship Some
Gastro-resistant and prolonged-release oral tablet Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility. An intended site for a dose form that is for administration by swallowing. true Inferred relationship Some
Gastro-resistant and prolonged-release oral tablet Has dose form administration method (attribute) A method of administration of a dose form by taking into the mouth and allowing to pass down the throat. true Inferred relationship Some
Gastro-resistant and prolonged-release oral tablet Has basic dose form (attribute) A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. true Inferred relationship Some
Gastro-resistant and prolonged-release oral tablet Is a Prolonged-release oral tablet true Inferred relationship Some
Gastro-resistant and prolonged-release oral tablet Has dose form transformation (attribute) No transformation true Inferred relationship Some
Gastro-resistant and prolonged-release oral tablet Has dose form release characteristic (attribute) A release characteristic where a dose form displays both a slower release of some of the active substance(s) than that of a conventional-release dose form and also displays a delayed release of some of the active substance(s) within the same dose form. This may be achieved by a special formulation design, manufacturing process or other methods. true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Paroxetine 12.5mg gastro-resistant and prolonged-release oral tablet Has manufactured dose form False Gastro-resistant and prolonged-release oral tablet Inferred relationship Some
Paroxetine 25mg gastro-resistant and prolonged-release oral tablet Has manufactured dose form False Gastro-resistant and prolonged-release oral tablet Inferred relationship Some
Paroxetine 37.5mg gastro-resistant and prolonged-release oral tablet Has manufactured dose form False Gastro-resistant and prolonged-release oral tablet Inferred relationship Some
Product containing precisely domperidone (as domperidone maleate) 30 milligram and pantoprazole (as pantoprazole sodium) 40 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) Has manufactured dose form True Gastro-resistant and prolonged-release oral tablet Inferred relationship Some
Domperidone 30 mg and omeprazole 20 mg gastro-resistant and prolonged-release oral capsule Has manufactured dose form False Gastro-resistant and prolonged-release oral tablet Inferred relationship Some
Product containing precisely dexrabeprazole sodium 10 milligram and domperidone 30 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) Has manufactured dose form True Gastro-resistant and prolonged-release oral tablet Inferred relationship Some
Product containing precisely levosulpiride 75 milligram and rabeprazole sodium 20 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) Has manufactured dose form True Gastro-resistant and prolonged-release oral tablet Inferred relationship Some
Mesalazine 1.6 g gastro-resistant and prolonged-release oral tablet Has manufactured dose form True Gastro-resistant and prolonged-release oral tablet Inferred relationship Some
Product containing precisely mesalazine 500 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) Has manufactured dose form True Gastro-resistant and prolonged-release oral tablet Inferred relationship Some
Product containing precisely mesalazine 1.2 gram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) Has manufactured dose form True Gastro-resistant and prolonged-release oral tablet Inferred relationship Some
Product containing precisely mesalazine 400 milligram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) Has manufactured dose form True Gastro-resistant and prolonged-release oral tablet Inferred relationship Some
Mesalazine 800 mg gastro-resistant and prolonged-release oral tablet Has manufactured dose form True Gastro-resistant and prolonged-release oral tablet Inferred relationship Some
Mesalazine 250 mg gastro-resistant and prolonged-release oral tablet Has manufactured dose form True Gastro-resistant and prolonged-release oral tablet Inferred relationship Some
Product containing precisely mesalazine 1 gram/1 each gastro-resistant and prolonged-release oral tablet (clinical drug) Has manufactured dose form True Gastro-resistant and prolonged-release oral tablet Inferred relationship Some

This concept is not in any reference sets

Back to Start